HighMark Wealth Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.68K | Hold |
397
| – | – | ﹤0.01% | 433 |
|
|
2025
Q1 | $2.91K | Hold |
397
| – | – | ﹤0.01% | 423 |
|
|
2024
Q4 | $3.39K | Hold |
397
| – | – | ﹤0.01% | 409 |
|
|
2024
Q3 | $3.45K | Hold |
397
| – | – | ﹤0.01% | 435 |
|
|
2024
Q2 | $2.72K | Hold |
397
| – | – | ﹤0.01% | 444 |
|
|
2024
Q1 | $3.61K | Hold |
397
| – | – | ﹤0.01% | 401 |
|
|
2023
Q4 | $1.77K | Hold |
397
| – | – | ﹤0.01% | 477 |
|
|
2023
Q3 | $1.25K | Hold |
397
| – | – | ﹤0.01% | 489 |
|
|
2023
Q2 | $2.05K | Hold |
397
| – | – | ﹤0.01% | 458 |
|
|
2023
Q1 | $2.09K | Hold |
397
| – | – | ﹤0.01% | 497 |
|
|
2022
Q4 | $1.12K | Hold |
397
| – | – | ﹤0.01% | 466 |
|
|
2022
Q3 | $2K | Hold |
397
| – | – | ﹤0.01% | 435 |
|
|
2022
Q2 | $2K | Hold |
397
| – | – | ﹤0.01% | 440 |
|
|
2022
Q1 | $2K | Hold |
397
| – | – | ﹤0.01% | 451 |
|
|
2021
Q4 | $3K | Hold |
397
| – | – | ﹤0.01% | 411 |
|
|
2021
Q3 | $4K | Hold |
397
| – | – | ﹤0.01% | 391 |
|
|
2021
Q2 | $6K | Hold |
397
| – | – | ﹤0.01% | 334 |
|
|
2021
Q1 | $7K | Hold |
397
| – | – | 0.01% | 301 |
|
|
2020
Q4 | $8K | Sell |
397
-2,000
| -83% | -$40.3K | 0.01% | 271 |
|
|
2020
Q3 | $18K | Hold |
2,397
| – | – | 0.02% | 177 |
|
|
2020
Q2 | $20K | Hold |
2,397
| – | – | 0.02% | 135 |
|
|
2020
Q1 | $11K | Hold |
2,397
| – | – | 0.01% | 146 |
|
|
2019
Q4 | $9K | Buy |
+2,397
| New | +$9K | 0.01% | 228 |
|